IRWD

Ironwood Pharmaceuticals, Inc.

A Boston-based biotechnology company that develops and sells medicines for digestive and rare diseases, best known for Linzess, a prescription treatment for chronic constipation and irritable bowel syndrome. It began in 1998 as Microbia, founded by postdocs from a Whitehead Institute lab, and renamed itself Ironwood in 2008 after the long-lived desert tree that shelters other plants — a nod to endurance. Its flagship drug linaclotide was discovered by those same early researchers.

Recent Activity

Show $

2024Q3

1 sell

First Eagle Investment ManagementEXIT

-1.10M shares

First Eagle Investment ManagementEXIT

-1.10M shares

2024Q2

1 buy

First Eagle Investment ManagementADD

+102.0K shares(+10.2%)

First Eagle Investment ManagementADD

+102.0K shares(+10.2%)

2024Q1

1 buy

First Eagle Investment ManagementADD

+95.0K shares(+10.5%)

First Eagle Investment ManagementADD

+95.0K shares(+10.5%)

Loading more activity...